Key result
SRPK3/TTN-digenic myopathy presents by 15 months with weakness and imaging indistinguishable from monogenic biallelic titinopathy.
Why the study?
SRPK3/TTN-digenic myopathy was recently established as a skeletal muscle myopathy, motivating characterization of its early clinical presentation.
Observational (n=8)
SRPK3/TTN-digenic myopathy presents with early clinical manifestations, muscle imaging patterns, and histopathological features that mimic monogenic biallelic titinopathy, aiding in clinical diagnosis.
Mostly normal cardiac evaluations in SRPK3/TTN-digenic myopathy suggest limited screening need; leaves open larger cohort confirmation.
Objective SRPK3/TTN ‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN ‐digenic myopathy in one previously reported and seven newly identified pediatric patients. Methods Next generation sequencing and deep clinical phenotyping provide detailed genetic, clinical, imaging, and histopathological characterization of SRPK3/TTN‐ digenic myopathy. Results From the cohort of eight male patients (5–19 years at last evaluation), five presented prenatally with reduced fetal movements. At the time of birth, five had hypotonia, two had contractures, and two had respiratory distress. All patients demonstrated motor delay and muscle weakness within the first 15 months of life. Independent ambulation was achieved in six patients (ages 1.5–4 years); three could run. Variable respiratory compromise was documented as early as 5 years of age, with one patient requiring non‐invasive nocturnal ventilation support. Cardiac evaluation was normal in all except one patient who had left ventricular non‐compaction cardiomyopathy. Muscle MRI demonstrated mild, slowly progressive fibroadipose replacement of muscle with striking early selective involvement of the semitendinosus muscle. Histopathologic and ultrastructural features mimicked TTN ‐related myopathy (titinopathy), showing abnormal fiber size variation, increased internally placed nuclei, type 1 fiber predominance, and cores/minicores. Interpretation This work highlights the early clinical manifestations of SRPK3/TTN ‐digenic myopathy and demonstrates early muscle imaging patterns and histopathological features that are indistinct from those observed in monogenic biallelic titinopathy cases. These features could help with the potentially challenging interpretation of digenic SRPK3 and TTN variants to allow for a confident clinical diagnosis of this novel congenital myopathy.
No takes yet. Share an insight, caveat, or question.
Orbach et al. (2026) conducted an observational in SRPK3/TTN-digenic myopathy (n=8).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: